Table 1. Demographic and clinical variables of participants in relation to PTSD symptoms.
| PTSD symptoms | ||||||
|---|---|---|---|---|---|---|
| Demographic variables | n | % | Mean | SD | F/t value | P value |
| Age (years) | 0.42 | 0.66 | ||||
| ≤ 35 | 72 | 32.0 | 32.64 | 12.64 | ||
| 36–55 | 84 | 37.3 | 32.81 | 11.51 | ||
| ≥ 56 | 69 | 30.7 | 31.12 | 12.64 | ||
| Mean (SD) | 45.30 (16.02) | |||||
| Median (Range) | 47.00 (15–83) | |||||
| Gender | 0.05 | 0.96 | ||||
| Men | 117 | 52.0 | 32.27 | 11.77 | ||
| Women | 108 | 48.0 | 32.20 | 12.71 | ||
| Marital status | 0.07 | 0.94 | ||||
| Married/cohabiting | 177 | 78.7 | 32.35 | 11.76 | ||
| Single/divorced/widowed/separated | 48 | 21.3 | 32.21 | 12.35 | ||
| Educational level | 2.34 | 0.06 | ||||
| Primary school or below | 20 | 8.9 | 31.98 | 14.19 | ||
| Junior high school | 88 | 39.1 | 34.18 | 12.68 | ||
| Senior high school | 41 | 18.2 | 30.88 | 10.54 | ||
| Junior college | 34 | 15.1 | 27.20 | 8.70 | ||
| University or above | 42 | 18.7 | 33.69 | 13.26 | ||
| Household monthly income (yuan) | 0.56 | 0.64 | ||||
| ≤ 1000 | 87 | 38.7 | 33.45 | 12.20 | ||
| 1001–2000 | 66 | 29.3 | 30.90 | 11.67 | ||
| 2001–3000 | 36 | 16.0 | 32.04 | 10.71 | ||
| ≥ 3000 | 36 | 16.0 | 31.96 | 14.56 | ||
| Place of residence | 1.36 | 0.18 | ||||
| Urban | 142 | 63.1 | 31.39 | 12.11 | ||
| Rural | 83 | 36.9 | 33.68 | 12.29 | ||
| Payment type | 0.48 | 0.63 | ||||
| Medical insurance | 172 | 76.4 | 32.02 | 12.21 | ||
| Self-payment | 53 | 23.6 | 32.94 | 12.24 | ||
| Clinical variables | ||||||
| Disease type | 1.67 | 0.10 | ||||
| Leukemia | 149 | 66.2 | 33.21 | 12.32 | ||
| Acute leukemia | 136 | 60.4 | ||||
| Chronic leukemia | 13 | 5.8 | ||||
| Non-leukemia | 76 | 33.8 | 30.34 | 11.81 | ||
| Multiple myeloma | 27 | 12.0 | ||||
| Myelodysplastic syndrome | 2 | 0.9 | ||||
| Non-Hodgkin’s lymphoma | 43 | 19.1 | ||||
| Hodgkin’s lymphoma | 4 | 1.8 | ||||
| Time since diagnosis (months) | 0.71 | 0.55 | ||||
| ≤ 3 | 101 | 44.9 | 31.36 | 12.01 | ||
| 4–6 | 42 | 18.7 | 33.20 | 11.31 | ||
| 7–12 | 31 | 13.8 | 30.97 | 13.34 | ||
| > 12 | 31 | 22.7 | 33.95 | 12.66 | ||
| Mean (SD) a | 4.50 (3.52) | |||||
| Median (Range) | 4.00 (1–85) | |||||
| Disease status | 1.41 | 0.25 | ||||
| New onset | 49 | 21.8 | 30.97 | 11.83 | ||
| Relapse/treatment failure | 58 | 25.8 | 34.50 | 12.82 | ||
| Persistence | 118 | 52.4 | 31.65 | 11.99 | ||
| Phase of chemotherapy | 2.07 | 0.13 | ||||
| None or inductive therapy | 89 | 39.6 | 30.22 | 11.63 | ||
| Consolidation therapy | 108 | 48.0 | 33.71 | 11.72 | ||
| Intensive therapy | 28 | 12.4 | 32.99 | 15.08 | ||
| Other chronic comorbidity | 0.12 | 0.91 | ||||
| Yes | 96 | 42.7 | 32.35 | 12.30 | ||
| No | 129 | 57.3 | 32.15 | 12.17 | ||
PTSD = posttraumatic stress disorder, SD = standard deviation.
aThe mean is logarithmic.